Latest Celtaxsys Inc. Stories
ATLANTA, June 2, 2015 /PRNewswire/ -- Celtaxsys, a clinical stage drug development company focused on advancing care for patients suffering from inflammatory diseases, including those with rare
ATLANTA, April 7, 2015 /PRNewswire/ -- Atlanta-based pharmaceutical company Celtaxsys, Inc.
ATLANTA, Nov. 6, 2014 /PRNewswire/ -- Celtaxsys, Inc. is pleased to announce the appointment of Sanjeev Ahuja, MD, MBA, FACP as Chief Medical Officer, effective November 1, 2014.
SAN FRANCISCO, June 6, 2011 /PRNewswire/ -- Celtaxsys, Inc., a private biopharmaceutical company defining new therapeutics in inflammation, announces the appointment of life sciences industry veteran, H. Daniel Perez, M.D., to its Board of Directors (BOD). "We are delighted that Dr.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.